Related Experiment Video
Updated: Sep 21, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Primate Erythroparvovirus 1 Infection in Patients with Hematological Disorders
Stefka Krumova1, Ivona Andonova1, Radostina Stefanova1
1National Reference Laboratory "Measles, Mumps, Rubella", Department of Virology, National Center of Infectious and Parasitic Diseases, 1233 Sofia, Bulgaria.
Insights
Primate erythroparvovirus 1 (B19V) frequently infects patients with hematological disorders. Testing for B19V DNA and antibodies is crucial for accurate diagnosis and management in these vulnerable individuals.
Area of Science:
- Virology
- Hematology
- Immunology
Background:
- Primate erythroparvovirus 1 (B19V) causes erythema infectiosum and can lead to persistent anemia, especially in immunocompromised individuals.
- Dialysis patients are susceptible to B19V-induced anemia.
Purpose of the Study:
- To investigate the prevalence of B19V infections in patients with hematological disorders.
- To assess the diagnostic utility of B19V DNA and antibody testing in this patient group.
Main Methods:
- Laboratory investigation of 21 patients with hematological disorders for B19V.
- Detection of B19V DNA and specific IgM antibodies.
- Genotyping of B19V DNA sequences.
- Laboratory monitoring of infected patients over one year.
Main Results:
- B19V DNA was detected in 13 (62%) of the patients.
- Three patients tested positive for specific IgM antibodies.
- Persistent B19V infection markers were found in only two patients after one year.
- Sequences from four samples clustered with B19V genotype 1a.
Conclusions:
- B19V infection is common in patients with hematological disorders.
- Routine screening for B19V DNA and antibodies is recommended for accurate diagnosis and management.
- Most B19V infections in this cohort resolved within a year.
Abstract:
Primate erythroparvovirus 1, commonly referred to as Parvovirus B19 (B19V), is a DNA virus that normally results in a mild childhood infection called "erythema infectiosum". Besides respiratory spread, B19V can also be transmitted through transfusions, which may result in persistent anemia in immunodeficient hosts. Dialysis patients often face acute or chronic anemia after infection with B19V. Here, we describe the laboratory investigation of 21 patients with hematological disorders for B19V infections. B19V DNA was detected in 13 (62%) of them, with specific IgM antibodies in three of the DNA positives. All 13 patients received treatment and were laboratory-monitored over a period of one year. In only two patients (a 14-year-old child with a kidney transplantation and a 39-year-old patient with aplastic anemia), markers of recent B19V infection were still detectable in follow-up samples. For four B19V DNA positive samples, short sequences could be obtained, which clustered with genotype 1a reference strains. Our findings suggest that all cases of hematological disorders should be examined for specific B19V antibodies and DNA for accurate diagnosis and appropriate patient management.
Related Concept Videos
Erythropoiesis
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...

